14.79
price up icon5.12%   0.72
after-market Dopo l'orario di chiusura: 14.86 0.07 +0.47%
loading

Moonlake Immunotherapeutics Azioni (MLTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
27.83%
60.70
47.48 49.58 43.11 -
Operating Income/Loss
27.83%
-60.70
-47.48 -49.58 -43.11 -
Income/Loss From Continuing Operations Before Tax
37.96%
-55.96
-40.56 -46.35 -36.02 -24.76
Income Tax Expense/Benefit
37.91%
0.095
0.153 0.0411 0.0921 -
Income/Loss From Continuing Operations After Tax
38.20%
-56.05
-40.56 -46.40 -36.11 -24.76
Net Income/Loss
38.20%
-56.05
-40.56 -46.40 -36.11 -24.76
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
35.12%
-0.831
-0.615 -0.7912 -0.7241 -
Basic Average Shares
0.08%
63.28
63.23 0.067 62.90 -
Diluted Average Shares
0.08%
63.28
63.23 0.067 62.90 -
Basic Earnings Per Share
38.10%
-0.87
-0.63 -0.72 -0.56 -
Diluted Earnings Per Share
38.10%
-0.87
-0.63 -0.72 -0.56 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):